HomeNRBO • NASDAQ
add
Neurobo Pharmaceuticals Inc
Previous close
$4.56
Day range
$4.59 - $4.74
Year range
$2.89 - $6.75
Market cap
22.86M USD
Avg Volume
25.49K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 6.88M | 173.06% |
Net income | -6.71M | -157.83% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -6.88M | -173.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 15.99M | -48.11% |
Total assets | 17.02M | -45.95% |
Total liabilities | 6.94M | -36.78% |
Total equity | 10.08M | — |
Shares outstanding | 4.91M | — |
Price to book | 2.22 | — |
Return on assets | -86.45% | — |
Return on capital | -126.72% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -6.71M | -157.83% |
Cash from operations | -6.44M | -152.93% |
Cash from investing | -5.00K | -25.00% |
Cash from financing | — | — |
Net change in cash | -6.45M | -152.72% |
Free cash flow | -4.14M | -39.91% |
About
Founded
2014
Website
Employees
8